The study indicates that combining semaglutide with trevogrumab (anti-GDF8/anti-myostatin) helped prevent about half of the lean mass loss typically associated with GLP-1 therapy, while increasing fat loss
By wrapping the glutathione in this lipid shell, we protect it from being destroyed in the digestive tract
The data is limited, and the use of L-arginine in patients with a history of heart attack or kidney disease is generally contraindicated, since L-arginine can actually increase the risk for complications in these populations. Under the guidance of your doctor, dietary strategies, along with medication, will likely also be implemented to help lower blood pressure
They'll also have access to a range of psychology-based programming and tools to help keep them from losing muscle mass, such as features for tracking protein intake and engaging in resistance training, Noom said
Neither provides enough progressive resistance to counteract GLP-1 muscle loss
